The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Nature

Volumn 436, Issue 7054, 2005, Pages 1186-1190

  Gasser, Stephan ^a   Orsulic, Sandra ^b   Brown, Eric J ^c   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; GENETIC ENGINEERING; IMMUNOLOGY; PROTEINS;

CELL CYCLE; CHRONIC ACTIVATION; GENETIC INHIBITION; IMMUNE SYSTEM;

DNA;

ATM PROTEIN; ATR PROTEIN; CD8 ANTIGEN; CHECKPOINT KINASE 1; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN KINASE; SMALL INTERFERING RNA;

DAMAGE; DNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; ENZYME INHIBITION; GENE EXPRESSION; GENE TARGETING; GENOTOXICITY; IMMUNE SYSTEM; IMMUNOREGULATION; MITOSIS INHIBITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; STRESS; T LYMPHOCYTE ACTIVATION; TUMOR CELL LINE;

ANIMALS; APHIDICOLIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPLICATION; FIBROBLASTS; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; KINETICS; LIGANDS; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, IMMUNOLOGIC; UP-REGULATION;

ATAXIA TELANGIECTASIA;

EID: 24144443517     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03884     Document Type: Article

References (27)

1. Raulet, D. H. Roles of the NKG2D immunoreceptor and its ligands. Nature Rev. Immunol. 3, 781-790 (2003).
2. Abraham, R. T. Cell cycle checkpoint signalling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196 (2001).
3. Xing, D. & Orsulic, S. A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumour resistance. Proc. Natl Acad. Sci. USA 102, 6936-6941 (2005).
4. Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003).
5. Osborn, A. J., Elledge, S. J. & Zou, L. Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol. 12, 509-516 (2002).
6. Sancar, A., Lindsey-Boltz, L. A., Unsal-Kaccmaz, K. & Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39-85 (2004).
7. Sarkaria, J. N. et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59, 4375-4382 (1999).
8. Brown, E. J. & Baltimore, D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 17, 615-628 (2003).
9. Nyberg, K. A., Michelson, R. J., Putnam, C. W. & Weinert, T. A. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36, 617-656 (2002).
10. Weitzman, M. D., Carson, C. T., Schwartz, R. A. & Lilley, C. E. Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst.) 3, 1165-1173 (2004).
11. Lodoen, M. et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197, 1245-1253 (2003).
12. Bartek, J. & Lukas, J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429 (2003).
13. Mills, K. D., Ferguson, D. O. & Alt, F. W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194, 77-95 (2003).
14. Sieber, O. M., Heinimann, K. & Tomlinson, I. P. Genomic instability-the engine of tumorigenesis? Nature Rev. Cancer 3, 701-708 (2003).
15. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).
16. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
17. Gonzalez, S., Prives, C. & Cordon-Cardo, C. p73alpha regulation by Chk1 in response to DNA damage. Mol. Cell. Biol. 23, 8161-8171 (2003).
18. Bignami, M., Casorelli, I. & Karran, P. Mismatch repair and response to DNA-damaging antitumour therapies. Eur. J. Cancer 39, 2142-2149 (2003).
19. Zhou, B. B. & Bartek, J. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nature Rev. Cancer 4, 216-225 (2004).
20. Jamieson, A. M. et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19-29 (2002).
21. Brown, E. J. & Baltimore, D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14, 397-402 (2000).
22. Lander, M. R., Moll, B. & Rowe, W. P. A procedure for culture of cells from mouse tail biopsies: brief communication. J. Natl Cancer Inst. 60, 477-478 (1978).
23. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. & Raulet, D. H. Ligands for the murine NKG2D receptor: expression by tumour cells and activation of NK cells and macrophages. Nature Immunol. 1, 119-126 (2000).
24. Diefenbach, A., Hsia, J. K., Hsiung, M. Y. & Raulet, D. H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumour immunity. Eur. J. Immunol. 33, 381-391 (2003).
25. Krause, D. R. et al. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene 22, 5927-5937 (2003).
26. Zhang, X. et al. Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response. Mol. Cell. Biol. 24, 9207-9220 (2004).
27. Hernandez-Hoyos, G., Anderson, M. K., Wang, C., Rothenberg, E. V. & Alberola-Ila, J. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19, 83-94 (2003).